Syndrome  >>  Kenketsu Glovenin-I (normal human immunoglobulin IV)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kenketsu Glovenin-I (normal human immunoglobulin IV) / Takeda
NCT02221271: Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome

Completed
3
22
Japan
NPB-01
Nihon Pharmaceutical Co., Ltd
Guillain-Barré Syndrome
08/15
08/15

Download Options